Crunching the numbers for LQDA... Refresh in a moment for the full analysis.
Liquidia Corp (LQDA)
Healthcare
weak
$38.55
Updated: 2026-04-12
37
TradeApes Score
reduce
Financial Strength
25
Stressed
Operating Trend
45
Mixed
Valuation
40
Weak
Capital Allocation
30
Weak
Risk
50
Mixed
Key Findings
+
Strong revenue growth — sales up more than 20% year over year
−
High leverage — net debt/EBITDA between 3× and 5×
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.